Eurobio Scientific Société anonyme (ENXTPA:ALERS) signed a definitive agreement to acquire EndoPredict business of Myriad Genetics, Inc (NasdaqGS:MYGN) for $10 million on May 6, 2024. The deal is subject to customary closing conditions, and Myriad expects the transaction to close in the second or third quarter of 2024.